Prajnan Das

Prajsnan Das is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in gastrointestinal oncology, radiation oncology, and surgical oncology. His research focuses on multimodal treatment strategies for gastric, rectal, and hepatobiliary cancers, including neoadjuvant therapy response staging, liver-directed radiotherapy for cholangiocarcinoma, and survivorship trajectories in recurrent rectal cancer. He has contributed to NCCN Clinical Practice Guidelines for gastric cancer and published on palliative oophorectomy for metastatic gastric adenocarcinoma, germline testing platforms for young-onset colorectal cancer, and imaging-based biomarkers of radiotherapy response. His work integrates clinical trials, translational imaging, and cancer survivorship research to optimize personalized care.